Good Clinical Practice (GCP) Compliance

Audit Trail Exports, Retention and Readability for Regulators

Posted on By digi

Audit Trail Exports, Retention and Readability for Regulators In the complex landscape of clinical trials, maintaining a comprehensive, transparent, and navigable audit trail is paramount for compliance with regulatory standards set forth by agencies such as the FDA, EMA, and MHRA. This article provides a detailed, step-by-step tutorial on ensuring that your audit trail exports,…

Read More “Audit Trail Exports, Retention and Readability for Regulators” »

Audit Trails & Data Traceability

Aligning Audit Trail Practices With ALCOA++ and ICH Expectations

Posted on By digi

Aligning Audit Trail Practices With ALCOA++ and ICH Expectations Aligning Audit Trail Practices With ALCOA++ and ICH Expectations In the evolving landscape of clinical trials, the integrity and reliability of data are paramount. This necessity is encapsulated in ALCOA++, an acronym standing for Attributable, Legible, Contemporaneous, Original, Accurate, and with the additional considerations of Complete…

Read More “Aligning Audit Trail Practices With ALCOA++ and ICH Expectations” »

Audit Trails & Data Traceability

Incorporating Audit Trail Checks Into Routine QA and QC Plans

Posted on By digi

Incorporating Audit Trail Checks Into Routine QA and QC Plans Incorporating Audit Trail Checks Into Routine QA and QC Plans The importance of audit trails in clinical trials cannot be overstated, particularly in the context of ensuring compliance with regulatory mandates and maintaining data integrity in clinical trials conducted globally, including the world wide clinical…

Read More “Incorporating Audit Trail Checks Into Routine QA and QC Plans” »

Audit Trails & Data Traceability

Classifying Deviations, Violations and Serious Breaches Under GCP

Posted on By digi

Classifying Deviations, Violations and Serious Breaches Under GCP Classifying Deviations, Violations and Serious Breaches Under GCP In the realm of clinical research, adherence to Good Clinical Practice (GCP) is non-negotiable. Deviations, violations, and serious breaches of GCP can undermine the integrity of clinical trials and the trust of stakeholders involved in the clinical research ecosystem….

Read More “Classifying Deviations, Violations and Serious Breaches Under GCP” »

Dealing with Non-Compliance under GCP

Managing GCP Non-Compliance: From Detection to Resolution

Posted on By digi

Managing GCP Non-Compliance: From Detection to Resolution Good Clinical Practice (GCP) is an essential framework for ensuring the integrity of clinical trials and the protection of patient rights. When non-compliance occurs, it presents significant risks to trial validity, patient safety, and can lead to regulatory penalties. This article provides a comprehensive step-by-step tutorial for clinical…

Read More “Managing GCP Non-Compliance: From Detection to Resolution” »

Dealing with Non-Compliance under GCP

Immediate Containment Actions When Serious GCP Breaches Are Identified

Posted on By digi

Immediate Containment Actions When Serious GCP Breaches Are Identified Immediate Containment Actions When Serious GCP Breaches Are Identified In the realm of clinical research services, serious breaches of Good Clinical Practice (GCP) can pose significant risks to trial integrity, patient safety, and scientific validity. When such breaches are identified, it is imperative that timely and…

Read More “Immediate Containment Actions When Serious GCP Breaches Are Identified” »

Dealing with Non-Compliance under GCP

Root Cause Analysis Techniques for Recurring Non-Compliance

Posted on By digi

Root Cause Analysis Techniques for Recurring Non-Compliance Root Cause Analysis Techniques for Recurring Non-Compliance In the clinical research landscape, adherence to regulatory standards is paramount. Non-compliance can hinder the integrity of clinical trials and negatively impact patient safety and data validity. This guide outlines a step-by-step approach to conducting Root Cause Analysis (RCA) for recurring…

Read More “Root Cause Analysis Techniques for Recurring Non-Compliance” »

Dealing with Non-Compliance under GCP

Regulatory and Ethics Reporting Requirements for Serious Breaches

Posted on By digi

Regulatory and Ethics Reporting Requirements for Serious Breaches Regulatory and Ethics Reporting Requirements for Serious Breaches In the realm of clinical trials, the significance of compliance with regulations and ethical guidelines cannot be overstated. Serious breaches in these areas can have profound implications not only for the integrity of a trial but also for the…

Read More “Regulatory and Ethics Reporting Requirements for Serious Breaches” »

Dealing with Non-Compliance under GCP

Communication Pathways for Escalating GCP Non-Compliance

Posted on By digi

Communication Pathways for Escalating GCP Non-Compliance Effective management of Good Clinical Practice (GCP) non-compliance is critical to ensuring the safety and welfare of study participants, as well as the integrity of clinical trial data. Communication pathways play a vital role in addressing and escalating issues of non-compliance in clinical trials, particularly in the context of…

Read More “Communication Pathways for Escalating GCP Non-Compliance” »

Dealing with Non-Compliance under GCP

Documenting Non-Compliance Cases in TMF, QA and Governance Forums

Posted on By digi

Documenting Non-Compliance Cases in TMF, QA and Governance Forums Documenting Non-Compliance Cases in TMF, QA and Governance Forums In the realm of clinical trials, maintaining compliance with regulatory standards is not merely a best practice; it is a fundamental necessity. The implications of non-compliance are profound, impacting not just the integrity of clinical data, but…

Read More “Documenting Non-Compliance Cases in TMF, QA and Governance Forums” »

Dealing with Non-Compliance under GCP